Table 1 Baseline characteristics of patients
Study group A (n = 64) | Study group B (n = 66) | Control group (n = 60) | P-value | |
|---|---|---|---|---|
Age (year) | 33.83 ± 5.10 | 33.36 ± 4.80 | 33.58 ± 5.04 | > 0.05 |
Gravidity | 2 (1,4) | 2 (1,7) | 2 (1,7) | > 0.05 |
Parity | 0 (0,2) | 0 (0,1) | 0 (0,1) | > 0.05 |
Gestational age (week) | 37.73 ± 1.33 | 37.91 ± 1.17 | 37.7 ± 1.45 | > 0.05 |
Size of largest myoma (cm) | 9 (8,15) | 9 (8,17) | 9 (8,18) | > 0.05 |
Number of myomas | 1 (1,5) | 2 (1,5) | 1 (1,4) | > 0.05 |
Localization (FIGOclassification) | > 0.05 | |||
Taype (3,5) | 42 (65.6) | 43 (65.2) | 40 (66.7) | |
Taype (4) | 22 (34.4) | 23 (34.8) | 20 (33.3) | |
CS indications | ||||
Previous CS | 15 (23.4) | 13 (19.7) | 20 (33.3) | > 0.05 |
Abnormal presentation | 10 (15.6) | 12 (18.2) | 16 (26.7) | > 0.05 |
Fetal distress | 5 (7.8) | 8 (12.1) | 10 (16.7) | > 0.05 |
Cephalo pelvic | > 0.05 | |||
Disproportion | 10 (15.6) | 11 (16.7) | 9 (15) | < 0.001 |
Social factors | 24 (37.5) | 22 (33.3) | 5 (8.3) |